http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008038003-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_274c349d1f7cceb61339df2bbc294dac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69c4816f98d40ffd9a0e62376e979d9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4578f7b51dfe463325b9e8ea22c85acf
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
filingDate 2007-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_865a2d104e0dfd89429872f8f1c82efa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b76db299c7d3fb8eb50fe40dd6d2b21
publicationDate 2008-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008038003-A3
titleOfInvention Pharmaceutical compositions of aripiprazole
abstract The present invention provides an orally deliverable pharmaceutical composition for the controlled release of aripiprazole. The composition comprises a therapeutically effective amount of aripiprazole and at least one pharmaceutically acceptable excipient. The compositions of the invention may exhibit one or more of the release profiles defined in this specification.
priorityDate 2006-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007035348-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005113009-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005032836-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005245539-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005046561-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005048979-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399498
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60795

Total number of triples: 43.